Streetbeat News

Stock Prices

CTAS

Cintas (NASDAQ:CTAS) has significantly outperformed the market over the past 10 years, delivering an average annual return of 26.83%. A $100 investment in Cintas 10 years ago would be worth $1,076.46 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

June 05, 2024 | 7:30 pm

BBWI

Bath & Body Works, Inc. (NYSE:BBWI) reported its first-quarter FY24 results with a 5.6% increase in inventories. Analysts from Goldman Sachs, BMO Capital Markets, JP Morgan, and BofA Securities provided their ratings and price forecasts, with a general positive outlook for the second half of the year. BBWI shares are trading higher by 3.74% to $46.86.

Portfolio Pulse from Nabaparna Bhattacharya

June 05, 2024 | 7:27 pm

AMGN

Amgen Inc (NASDAQ:AMGN) announced positive Phase 3 trial results for Uplizna in treating Immunoglobulin G4-related disease. The trial met all primary and secondary endpoints, showing significant efficacy and safety. Amgen plans to seek expanded US approval for Uplizna, which was acquired through a $27.8 billion deal with Horizon Therapeutics.

Portfolio Pulse from Vandana Singh

June 05, 2024 | 7:26 pm

ATAI

CYBN

MNMD

PSIL

FDA advisors rejected MDMA for PTSD treatment, causing a significant drop in psychedelic stocks. Cybin Inc (CYBN), Mind Medicine (MNMD), ATAI Life Sciences (ATAI), and AdvisorShares Psychedelics ETF (PSIL) all saw declines. The ruling is a setback for the industry, though the FDA is not bound by the advisory board's recommendation.

Portfolio Pulse from Aaron Bry

June 05, 2024 | 7:26 pm

MDT

Medtronic Plc (NYSE:MDT) has initiated a recall for some versions of its StealthStation S8 application due to a software error. The FDA classified the recall as Class I, the most serious kind. The error could lead to serious permanent injuries during cranial procedures. Medtronic plans to offer a software update to resolve the issue. MDT shares are down 1.41%.

Portfolio Pulse from Vandana Singh

June 05, 2024 | 7:23 pm

AKRO

ETNB

LLY

MDGL

SGMT

VKTX

On Wednesday, Madrigal Pharmaceuticals (MDGL) and Sagimet Biosciences (SGMT) stocks are trading lower following Eli Lilly's (LLY) presentation of positive Phase 2 trial results for tirzepatide in treating MASH at the EASL International Liver Congress 2024. Other companies working on MASH candidates include 89bio (ETNB), Akero Therapeutics (AKRO), and Viking Therapeutics (VKTX).

Portfolio Pulse from Vandana Singh

June 05, 2024 | 7:17 pm

TSLA

Tesla's FSD subscribers are canceling their subscriptions due to outdated software updates, leading to potential revenue loss for the company. The disconnect between Tesla's software rollout and customer expectations is causing dissatisfaction among users.

Portfolio Pulse from Benzinga EV Insights

June 05, 2024 | 7:16 pm

CACI

CACI International's short interest has fallen by 7.81%, with 233 thousand shares sold short, representing 1.18% of its float. This is lower than the peer group average of 3.17%. The decrease in short interest may indicate a more bullish sentiment towards the stock.

Portfolio Pulse from Benzinga Insights

June 05, 2024 | 7:15 pm

GLD

IAU

IVV

SPY

VOO

Ray Dalio, founder of Bridgewater Associates, warns of escalating U.S.-China tensions and the importance of diversification in investments. He highlights the risks of economic sanctions, internal U.S. conflicts, and global economic uncertainties. Dalio recommends diversifying across countries, currencies, and asset classes, and prefers equity over debt, with gold as a hedge.

Portfolio Pulse from Surbhi Jain

June 05, 2024 | 7:14 pm

SMCI

Super Micro Computer shares are trading higher after the company introduced a ready-to-deploy liquid-cooled AI data center.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 7:06 pm